InvestorsHub Logo
Followers 7
Posts 289
Boards Moderated 0
Alias Born 12/11/2013

Re: olden_grumpini post# 345670

Friday, 02/12/2021 8:31:21 AM

Friday, February 12, 2021 8:31:21 AM

Post# of 403018
Looks like the real world to me

" Brilacidin has already been successfully tested in clinical trials and shown to exhibit potent antibacterial activity in Phase 2 clinical trials for treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI), and anti-inflammatory activity, as supported in Phase 2 clinical trials for treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis. As such, brilacidin has already demonstrated HDP-like therapeutic properties in the clinic."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News